Key result
Hospital stay ≥5 days before rapid response system activation linked to ~60% higher 28-day mortality.
Why the study?
Predictors of survival outcome after rapid response system activation due to unexpected clinical deterioration are not well defined.
Does longer hospital length of stay before rapid response system activation predict worse clinical outcomes in hospitalized patients?
Cohort (n=11,612)
Yes
Does longer hospital length of stay before rapid response system activation predict worse clinical outcomes in hospitalized patients?
Odds Ratio: 1.6 (95% CI 1.44–1.77)
Absolute Event Rate: 25.4% vs 18.2%
p-value: p=<0.001
Patients who experience clinical deterioration requiring rapid response system activation later in their hospital stay (≥5 days) have a significantly higher risk of 28-day mortality.
Background: Rapid response system (RRS) has been increasingly adopted to improve patient safety in hospitals worldwide. However, predictors of survival outcome after RRS activation because of unexpected clinical deterioration are not well defined. We investigated whether hospital length of stay (LOS) before RRS activation can predict the clinical outcomes.Methods: Using a nationwide multicenter RRS database, we identified patients for whom RRS was activated during hospitalization at 9 tertiary referral hospitals in South Korea between January 1, 2016, and December 31, 2017. All information on patient characteristics, RRS activation, and clinical outcomes were retrospectively collected by reviewing patient medical records at each center. Patients were categorized into two groups according to their hospital LOS before RRS activation: early deterioration (LOS <5 days) and late deterioration (LOS ≥5 days). The primary outcome was 28-day mortality and multivariable logistic regression was used to compare the two groups. In addition, propensity score-matched analysis was used to minimize the effects of confounding factors.Results: Among 11,612 patients, 5,779 and 5,883 patients belonged to the early and late deterioration groups, respectively. Patients in the late deterioration group were more likely to have malignant disease and to be more severely ill at the time of RRS activation. After adjusting for confounding factors, the late deterioration group had higher 28-day mortality (aOR 1.60, 95% CI 1.44–1.77). Other clinical outcomes (in-hospital mortality and hospital LOS after RRS activation) were worse in the late deterioration group as well, and similar results were found in the propensity score-matched analysis (aOR for 28-day mortality 1.66, 95% CI 1.45–1.91).Conclusions: Patients who stayed longer in the hospital before RRS activation had worse clinical outcomes. During the RRS team review of patients, hospital LOS before RRS activation should be considered as a predictor of future outcome.
No takes yet. Share an insight, caveat, or question.
Park et al. (2020) conducted a cohort in Unexpected clinical deterioration requiring rapid response system activation (n=11,612). Late deterioration (hospital length of stay ≥ 5 days before RRS activation) vs. Early deterioration (hospital length of stay < 5 days before RRS activation) was evaluated on 28-day mortality (aOR 1.60, 95% CI 1.44-1.77, p=<0.001). A hospital length of stay of 5 or more days before rapid response system activation was associated with a significantly higher 28-day mortality compared to a stay of less than 5 days (aOR 1.60).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: